{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cannabis sativa", "bacterial resistance", "cannabichromene (CBC)", "cannabidiol (CBC)", "cannabigerol (CBG)", "endocannabinois (ECs)", "methicillin-resistant S. aureus (MRSA)", "multi drug resistant (MDR) bacteria", "phytocannabinoids (PCs)", "synthetic cannabinoids (SCs)", "synthetic procedures"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37514074", "DateRevised": {"Year": "2023", "Month": "08", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "05"}], "Language": ["eng"], "ELocationID": ["1889", "10.3390/pharmaceutics15071889"], "Journal": {"ISSN": "1999-4923", "JournalIssue": {"Volume": "15", "Issue": "7", "PubDate": {"Year": "2023", "Month": "Jul", "Day": "05"}}, "Title": "Pharmaceutics", "ISOAbbreviation": "Pharmaceutics"}, "ArticleTitle": "Synthetic Pathways to Non-Psychotropic Phytocannabinoids as Promising Molecules to Develop Novel Antibiotics: A Review.", "Abstract": {"AbstractText": ["Due to the rapid emergence of multi drug resistant (MDR) pathogens against which current antibiotics are no longer functioning, severe infections are becoming practically untreatable. Consequently, the discovery of new classes of effective antimicrobial agents with novel mechanism of action is becoming increasingly urgent. The bioactivity of <i>Cannabis sativa</i>, an herbaceous plant used for millennia for medicinal and recreational purposes, is mainly due to its content in phytocannabinoids (PCs). Among the 180 PCs detected, cannabidiol (CBD), \u0394<sup>8</sup> and \u0394<sup>9</sup>-tetrahydrocannabinols (\u0394<sup>8</sup>-THC and \u0394<sup>9</sup>-THC), cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN) and some of their acidic precursors have demonstrated from moderate to potent antibacterial effects against Gram-positive bacteria (MICs 0.5-8 \u00b5g/mL), including methicillin-resistant <i>Staphylococcus aureus</i> (MRSA), epidemic MRSA (EMRSA), as well as fluoroquinolone and tetracycline-resistant strains. Particularly, the non-psychotropic CBG was also capable to inhibit MRSA biofilm formation, to eradicate even mature biofilms, and to rapidly eliminate MRSA persiter cells. In this scenario, CBG, as well as other minor non-psychotropic PCs, such as CBD, and CBC could represent promising compounds for developing novel antibiotics with high therapeutic potential. Anyway, further studies are necessary, needing abundant quantities of such PCs, scarcely provided naturally by <i>Cannabis</i> plants. Here, after an extensive overture on cannabinoids including their reported antimicrobial effects, aiming at easing the synthetic production of the necessary amounts of CBG, CBC and CBD for further studies, we have, for the first time, systematically reviewed the synthetic pathways utilized for their synthesis, reporting both reaction schemes and experimental details."]}, "AuthorList": [{"Identifier": ["0000-0002-4630-4371"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy (DIFAR), University of Genoa, Viale Cembrano, 4, 16148 Genoa, Italy."}], "LastName": "Alfei", "ForeName": "Silvana", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Viale Benedetto XV, 6, 16132 Genova, Italy."}], "LastName": "Schito", "ForeName": "Gian Carlo", "Initials": "GC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Viale Benedetto XV, 6, 16132 Genova, Italy."}], "LastName": "Schito", "ForeName": "Anna Maria", "Initials": "AM"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceutics", "NlmUniqueID": "101534003", "ISSNLinking": "1999-4923"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Vivas R., Barbosa A.A.T., Dolabela S.S., Jain S. Multidrug-Resistant Bacteria and Alternative Methods to Control Them: An Overview. Microb. Drug Resist. 2019;25:890\u2013908. doi: 10.1089/mdr.2018.0319.", "ArticleIdList": ["10.1089/mdr.2018.0319", "30811275"]}, {"Citation": "Mancuso G., Midiri A., Gerace E., Biondo C. Bacterial Antibiotic Resistance: The Most Critical Pathogens. Pathogens. 2021;10:1310. doi: 10.3390/pathogens10101310.", "ArticleIdList": ["10.3390/pathogens10101310", "PMC8541462", "34684258"]}, {"Citation": "WHO  Antimicrobial Resistance.  [(accessed on 3 May 2023)].  Available online:  https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance."}, {"Citation": "Stojkovi\u0107 D., Petrovi\u0107 J., Carevi\u0107 T., Sokovi\u0107 M., Liaras K. Synthetic and Semisynthetic Compounds as Antibacterials Targeting Virulence Traits in Resistant Strains: A Narrative Updated Review. Antibiotics. 2023;12:963. doi: 10.3390/antibiotics12060963.", "ArticleIdList": ["10.3390/antibiotics12060963", "PMC10295040", "37370282"]}, {"Citation": "Chancey S.T., Zahner D., Stephens D.S. Acquired inducible antimicrobial resistance in Gram-positive bacteria. Future Microbiol. 2012;7:959\u2013978. doi: 10.2217/fmb.12.63.", "ArticleIdList": ["10.2217/fmb.12.63", "PMC3464494", "22913355"]}, {"Citation": "Spengler G., Kincses A., Gajdacs M., Amaral L. New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria. Molecules. 2017;22:468. doi: 10.3390/molecules22030468.", "ArticleIdList": ["10.3390/molecules22030468", "PMC6155429", "28294992"]}, {"Citation": "Schaenzer A.J., Wright G.D. Antibiotic Resistance by Enzymatic Modification of Antibiotic Targets. Trends Mol. Med. 2020;26:768\u2013782. doi: 10.1016/j.molmed.2020.05.001.", "ArticleIdList": ["10.1016/j.molmed.2020.05.001", "32493628"]}, {"Citation": "Wilson D.N., Hauryliuk V., Atkinson G.C., O\u2019Neill A.J. Target protection as a key antibiotic resistance mechanism. Nat. Rev. Microbiol. 2020;18:637\u2013648. doi: 10.1038/s41579-020-0386-z.", "ArticleIdList": ["10.1038/s41579-020-0386-z", "32587401"]}, {"Citation": "Larsson D.G.J., Flach C.F. Antibiotic resistance in the environment. Nat. Rev. Microbiol. 2022;20:257\u2013269. doi: 10.1038/s41579-021-00649-x.", "ArticleIdList": ["10.1038/s41579-021-00649-x", "PMC8567979", "34737424"]}, {"Citation": "Guetiya Wadoum R.E., Zambou N.F., Anyangwe F.F., Njimou J.R., Coman M.M., Verdenelli M.C., Cecchini C., Silvi S., Orpianesi C., Cresci A., et al. Abusive use of antibiotics in poultry farming in Cameroon and the public health implications. Br. Poult. Sci. 2016;57:483\u2013493. doi: 10.1080/00071668.2016.1180668.", "ArticleIdList": ["10.1080/00071668.2016.1180668", "27113432"]}, {"Citation": "Baynes R.E., Dedonder K., Kissell L., Mzyk D., Marmulak T., Smith G., Tell L., Gehring R., Davis J., Riviere J.E. Health concerns and management of select veterinary drug residues. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc. 2016;88:112\u2013122. doi: 10.1016/j.fct.2015.12.020.", "ArticleIdList": ["10.1016/j.fct.2015.12.020", "26751035"]}, {"Citation": "Ghosh C., Sarkar P., Issa R., Haldar J. Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance. Trend. Microbiol. 2019;27:323\u2013338. doi: 10.1016/j.tim.2018.12.010.", "ArticleIdList": ["10.1016/j.tim.2018.12.010", "30683453"]}, {"Citation": "Gupta A., Mumtaz S., Li C.H., Hussain I., Rotello V.M. Combatting antibiotic-resistant bacteria using nanomaterials. Chem. Soc. Rev. 2019;48:415\u2013427. doi: 10.1039/C7CS00748E.", "ArticleIdList": ["10.1039/C7CS00748E", "PMC6340759", "30462112"]}, {"Citation": "Sarkar D.J., Mohanty D., Raut S.S., Das B.K. Antibacterial properties and in silico odelling perspective of nano ZnO transported oxytetracycline-Zn2+ complex [ZnOTc]+ against oxytetracycline-resistant Aeromonas hydrophila. J. Antibiot. 2022;75:635\u2013649. doi: 10.1038/s41429-022-00564-0.", "ArticleIdList": ["10.1038/s41429-022-00564-0", "36123536"]}, {"Citation": "Li Q. Application of Fragment-Based Drug Discovery to Versatile Targets. Front. Mol. Biosci. 2020;7:180. doi: 10.3389/fmolb.2020.00180.", "ArticleIdList": ["10.3389/fmolb.2020.00180", "PMC7419598", "32850968"]}, {"Citation": "Boyd N.K., Teng C., Frei C.R. Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing. Front. Cell. Infect. Microbiol. 2021;11:684515. doi: 10.3389/fcimb.2021.684515.", "ArticleIdList": ["10.3389/fcimb.2021.684515", "PMC8165386", "34079770"]}, {"Citation": "Mazur M., Mas\u0142owiec D. Antimicrobial Activity of Lactones. Antibiotics. 2022;11:1327. doi: 10.3390/antibiotics11101327.", "ArticleIdList": ["10.3390/antibiotics11101327", "PMC9598898", "36289985"]}, {"Citation": "de Ruyck J., Dupont C., Lamy E., Le Moigne V., Biot C., Gu\u00e9rardel Y., Herrmann J.L., Blaise M., Grassin-Delyle S., Kremer L., et al. Structure-Based Design and Synthesis of Piperidinol-Containing Molecules as New Mycobacterium abscessus Inhibitors. Chem. Open. 2020;9:351\u2013365. doi: 10.1002/open.202000042.", "ArticleIdList": ["10.1002/open.202000042", "PMC7083170", "32211280"]}, {"Citation": "Dias C., Pais J.P., Nunes R., Bl\u00e1zquez-S\u00e1nchez M.-T., Marqu\u00eas J.T., Almeida A.F., Serra P., Xavier N.M., Vila-Vi\u00e7osa D., Machuqueiro M., et al. Sugar-based bactericides targeting phosphatidylethanolamine-enriched membranes. Nat. Commun. 2018;9:4857. doi: 10.1038/s41467-018-06488-4.", "ArticleIdList": ["10.1038/s41467-018-06488-4", "PMC6242839", "30451842"]}, {"Citation": "Thakur A., Verma M., Setia P., Bharti R., Sharma R., Sharma A., Negi N.P., Anand V., Bansal R. DFT analysis and in vitro studies of isoxazole derivatives as potent antioxidant and antibacterial agents synthesized via one-pot methodology. Res. Chem. Intermed. 2023;49:859\u2013883. doi: 10.1007/s11164-022-04910-7.", "ArticleIdList": ["10.1007/s11164-022-04910-7"]}, {"Citation": "Patil S.A., Patil S.A., Ble-Gonz\u00e1lez E.A., Isbel S.R., Hampton S.M., Bugarin A. Carbazole Derivatives as Potential Antimicrobial Agents. Molecules. 2022;27:6575. doi: 10.3390/molecules27196575.", "ArticleIdList": ["10.3390/molecules27196575", "PMC9573399", "36235110"]}, {"Citation": "Jubeh B., Breijyeh Z., Karaman R. Antibacterial Prodrugs to Overcome Bacterial Resistance. Molecules. 2020;25:1543. doi: 10.3390/molecules25071543.", "ArticleIdList": ["10.3390/molecules25071543", "PMC7180472", "32231026"]}, {"Citation": "Bassetti M., Kanj S.S., Kiratisin P., Rodrigues C., Van Duin D., Villegas M.V., Yu Y. Early appropriate diagnostics and treatment of MDR Gram-negative infections. JAC-Antimicrob. Resist. 2022;4:dlac089. doi: 10.1093/jacamr/dlac089.", "ArticleIdList": ["10.1093/jacamr/dlac089", "PMC9469888", "36111208"]}, {"Citation": "Tyers M., Wright G.D. Drug combinations: A strategy to extend the life of antibiotics in the 21st century. Nat. Rev. Microbiol. 2019;17:141\u2013155. doi: 10.1038/s41579-018-0141-x.", "ArticleIdList": ["10.1038/s41579-018-0141-x", "30683887"]}, {"Citation": "Alfei S., Schito A.M. \u03b2-Lactam Antibiotics and \u03b2-Lactamase Enzymes Inhibitors, Part 2: Our Limited Resources. Pharmaceuticals. 2022;15:476. doi: 10.3390/ph15040476.", "ArticleIdList": ["10.3390/ph15040476", "PMC9031764", "35455473"]}, {"Citation": "Alfei S., Zuccari G. Recommendations to Synthetize Old and New \u03b2-Lactamases Inhibitors: A Review to Encourage Further Production. Pharmaceuticals. 2022;15:384. doi: 10.3390/ph15030384.", "ArticleIdList": ["10.3390/ph15030384", "PMC8954882", "35337181"]}, {"Citation": "Karasneh R.A., Al-Azzam S.I., Ababneh M., Al-Azzeh O., Al-Batayneh O.B., Muflih S.M., Khasawneh M., Khassawneh A.M., Khader Y.S., Conway B.R., et al. Prescribers\u2019 Knowledge, Attitudes and Behaviors on Antibiotics, Antibiotic Use and Antibiotic Resistance in Jordan. Antibiotics. 2021;10:858. doi: 10.3390/antibiotics10070858.", "ArticleIdList": ["10.3390/antibiotics10070858", "PMC8300611", "34356779"]}, {"Citation": "Radwan M.M., Chandra S., Gul S., ElSohly M.A. Cannabinoids, Phenolics, Terpenes and Alkaloids of Cannabis. Molecules. 2021;26:2774. doi: 10.3390/molecules26092774.", "ArticleIdList": ["10.3390/molecules26092774", "PMC8125862", "34066753"]}, {"Citation": "Tahir M.N., Shahbazi F., Rondeau-Gagn\u00e9 S., Trant J.F. The biosynthesis of the cannabinoids. J. Cannabis. Res. 2021;3:7. doi: 10.1186/s42238-021-00062-4.", "ArticleIdList": ["10.1186/s42238-021-00062-4", "PMC7962319", "33722296"]}, {"Citation": "Pagano C., Navarra G., Coppola L., Avilia G., Bifulco M., Laezza C. Cannabinoids: Therapeutic Use in Clinical Practice. Int. J. Mol. Sci. 2022;23:3344. doi: 10.3390/ijms23063344.", "ArticleIdList": ["10.3390/ijms23063344", "PMC8952215", "35328765"]}, {"Citation": "Palomares B., Ruiz-Pino F., Garrido-Rodriguez M., Eugenia Prados M., S\u00e1nchez-Garrido M.A., Velasco I., Vazquez M.J., Nadal X., Ferreiro-Vera C., Morrugares R., et al. Tetrahydrocannabinolic Acid A (THCA-A) Reduces Adiposity and Prevents Metabolic Disease Caused by Diet-Induced Obesity. Biochem. Pharmacol. 2020;171:113693. doi: 10.1016/j.bcp.2019.113693.", "ArticleIdList": ["10.1016/j.bcp.2019.113693", "31706843"]}, {"Citation": "Pisanti S., Malfitano A.M., Ciaglia E., Lamberti A., Ranieri R., Cuomo G., Abate M., Faggiana G., Proto M.C., Fiore D., et al. Cannabidiol: State of the Art and New Challenges for Therapeutic Applications. Pharmacol. Ther. 2017;175:133\u2013150. doi: 10.1016/j.pharmthera.2017.02.041.", "ArticleIdList": ["10.1016/j.pharmthera.2017.02.041", "28232276"]}, {"Citation": "Farha M.A., El-Halfawy O.M., Gale R.T., MacNair C.R., Carfrae L.A., Zhang X., Jentsch N.G., Magolan J., Brown E.D. Uncovering the Hidden Antibiotic Potential of Cannabis. ACS Infect. Dis. 2020;6:338\u2013346. doi: 10.1021/acsinfecdis.9b00419.", "ArticleIdList": ["10.1021/acsinfecdis.9b00419", "32017534"]}, {"Citation": "Breijyeh Z., Karaman R. Design and Synthesis of Novel Antimicrobial Agents. Antibiotics. 2023;12:628. doi: 10.3390/antibiotics12030628.", "ArticleIdList": ["10.3390/antibiotics12030628", "PMC10045396", "36978495"]}, {"Citation": "Saleemi M.A., Yahaya N., Zain N.N.M., Raoov M., Yong Y.K., Noor N.S., Lim V. Antimicrobial and Cytotoxic Effects of Cannabinoids: An Updated Review with Future Perspectives and Current Challenges. Pharmaceuticals. 2022;15:1228. doi: 10.3390/ph15101228.", "ArticleIdList": ["10.3390/ph15101228", "PMC9607911", "36297340"]}, {"Citation": "Chen J., Zhang H., Wang S., Du Y., Wei B., Wu Q., Wang H. Inhibitors of Bacterial Extracellular Vesicles. Front. Microbiol. 2022;13:835058. doi: 10.3389/fmicb.2022.835058.", "ArticleIdList": ["10.3389/fmicb.2022.835058", "PMC8905621", "35283837"]}, {"Citation": "Luz-Veiga M., Amorim M., Pinto-Ribeiro I., Oliveira A.L.S., Silva S., Pimentel L.L., Rodr\u00edguez-Alcal\u00e1 L.M., Madureira R., Pintado M., Azevedo-Silva J., et al. Cannabidiol and Cannabigerol Exert Antimicrobial Activity without Compromising Skin Microbiota. Int. J. Mol. Sci. 2023;24:2389. doi: 10.3390/ijms24032389.", "ArticleIdList": ["10.3390/ijms24032389", "PMC9917174", "36768709"]}, {"Citation": "Blaskovich M.A.T., Kavanagh A.M., Elliott A.G., Zhang B., Ramu S., Amado M., Lowe G.J., Hinton A.O., Pham D.M.T., Zuegg J., et al. The antimicrobial potential of cannabidiol. Commun. Biol. 2021;4:7. doi: 10.1038/s42003-020-01530-y.", "ArticleIdList": ["10.1038/s42003-020-01530-y", "PMC7815910", "33469147"]}, {"Citation": "Gildea L., Ayariga J.A., Xu J., Villafane R., Robertson B.K., Samuel-Foo M., Ajayi O.S. Cannabis sativa CBD Extract Exhibits Synergy with Broad-Spectrum Antibiotics against Salmonella enterica subsp. Enterica serovar typhimurium. Microorganisms. 2022;10:2360. doi: 10.3390/microorganisms10122360.", "ArticleIdList": ["10.3390/microorganisms10122360", "PMC9784314", "36557613"]}, {"Citation": "Calapai F., Cardia L., Esposito E., Ammendolia I., Mondello C., Lo Giudice R., Gangemi S., Calapai G., Mannucci C. Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives. Evid.-Based Complement. Altern. Med. 2022;2022:3336516. doi: 10.1155/2022/3336516.", "ArticleIdList": ["10.1155/2022/3336516", "PMC9666035", "36397993"]}, {"Citation": "Whiting P.F., Wolff R.F., Deshpande S., Di Nisio M., Duffy S., Hernandez A.V., Keurentjes J.C., Lang S., Misso K., Ryder S., et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA. 2015;313:2456\u20132473. doi: 10.1001/jama.2015.6358.", "ArticleIdList": ["10.1001/jama.2015.6358", "26103030"]}, {"Citation": "Vu\u010dkovi\u0107 S., Srebro D., Vujovi\u0107 K.S., Vu\u010deti\u0107 \u010c., Prostran M. Cannabinoids and Pain: New Insights From Old Molecules. Front. Pharmacol. 2018;9:1259. doi: 10.3389/fphar.2018.01259.", "ArticleIdList": ["10.3389/fphar.2018.01259", "PMC6277878", "30542280"]}, {"Citation": "Lafaye G., Karila L., Blecha L., Benyamina A. Cannabis, Cannabinoids, and Health. DCNS. 2017;19:309\u2013316. doi: 10.31887/DCNS.2017.19.3/glafaye.", "ArticleIdList": ["10.31887/DCNS.2017.19.3/glafaye", "PMC5741114", "29302228"]}, {"Citation": "Berman P., Futoran K., Lewitus G.M., Mukha D., Benami M., Shlomi T., Meiri D. A New ESI-LC/MS Approach for Comprehensive Metabolic Profiling of Phytocannabinoids in Cannabis. Sci. Rep. 2018;8:14280. doi: 10.1038/s41598-018-32651-4.", "ArticleIdList": ["10.1038/s41598-018-32651-4", "PMC6155167", "30250104"]}, {"Citation": "Fraguas-S\u00e1nchez A.I., Fern\u00e1ndez-Carballido A., Torres-Su\u00e1rez A.I. Phyto-, Endo- and Synthetic Cannabinoids: Promising Chemotherapeutic Agents in the Treatment of Breast and Prostate Carcinomas. Expert. Opin. Investig. Drugs. 2016;25:1311\u20131323. doi: 10.1080/13543784.2016.1236913.", "ArticleIdList": ["10.1080/13543784.2016.1236913", "27633508"]}, {"Citation": "Mackie K. Cannabinoid Receptors: Where They are and What They do. J. Neuroendocr. 2008;20:10\u201314. doi: 10.1111/j.1365-2826.2008.01671.x.", "ArticleIdList": ["10.1111/j.1365-2826.2008.01671.x", "18426493"]}, {"Citation": "Brennecke B., Gazzi T., Atz K., Fingerle J., Kuner P., Schindler T., Weck G., Nazar\u00e9 M., Grether U. Cannabinoid receptor type 2 ligands: An analysis of granted patents since 2010. Pharm. Patent Anal. 2021;10:111\u2013163. doi: 10.4155/ppa-2021-0002.", "ArticleIdList": ["10.4155/ppa-2021-0002", "34111979"]}, {"Citation": "Gertsch J., Raduner S., Altmann K.-H. New Natural Noncannabinoid Ligands for Cannabinoid Type-2 (CB2) Receptors. J. Recept. Signal Transduct. 2006;26:709\u2013730. doi: 10.1080/10799890600942674.", "ArticleIdList": ["10.1080/10799890600942674", "17118807"]}, {"Citation": "Li X., Chang H., Bouma J., de Paus L.V., Mukhopadhyay P., Paloczi J., Mustafa M., van der Horst C., Kumar S.S., Wu L., et al. Structural Basis of Selective Cannabinoid CB2 Receptor Activation. Nat. Commun. 2023;14:1447. doi: 10.1038/s41467-023-37112-9.", "ArticleIdList": ["10.1038/s41467-023-37112-9", "PMC10017709", "36922494"]}, {"Citation": "Lambert D.M.  Ph.D. Thesis. University of British Columbia; Vancouver, BC, Canada: 2019.  [(accessed on 27 June 2023)]. Pharmacologic Targeting of the CB2 Cannabinoid Receptor for Application in Centrally-Mediated Chronic Pain. Available online:  https://open.library.ubc.ca/collections/ubctheses/24/items/1.0376050."}, {"Citation": "Fezza F., Bari M., Florio R., Talamonti E., Feole M., Maccarrone M. Endocannabinoids, Related Compounds and Their Metabolic Routes. Molecules. 2014;19:17078\u201317106. doi: 10.3390/molecules191117078.", "ArticleIdList": ["10.3390/molecules191117078", "PMC6271436", "25347455"]}, {"Citation": "Sharma D.S., Paddibhatla I., Raghuwanshi S., Malleswarapu M., Sangeeth A., Kovuru N., Dahariya S., Gautam D.K., Pallepati A., Gutti R.K. Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disorders. J. Neuroimmunol. 2021;353:577501. doi: 10.1016/j.jneuroim.2021.577501.", "ArticleIdList": ["10.1016/j.jneuroim.2021.577501", "33571815"]}, {"Citation": "Formato M., Crescente G., Scognamiglio M., Fiorentino A., Pecoraro M.T., Piccolella S., Catauro M., Pacifico S. (\u2212)-Cannabidiolic Acid, a Still Overlooked Bioactive Compound: An Introductory Review and Preliminary Research. Molecules. 2020;25:2638. doi: 10.3390/molecules25112638.", "ArticleIdList": ["10.3390/molecules25112638", "PMC7321064", "32517131"]}, {"Citation": "Nguyen G.N., Jordan E.N., Kayser O. Synthetic Strategies for Rare Cannabinoids Derived from Cannabis sativa. J. Nat. Prod. 2022;85:1555\u20131568. doi: 10.1021/acs.jnatprod.2c00155.", "ArticleIdList": ["10.1021/acs.jnatprod.2c00155", "35648593"]}, {"Citation": "Schwilke E.W., Schwope D.M., Karschner E.L., Lowe R.H., Darwin W.D., Kelly D.L., Goodwin R.S., Gorelick D.A., Huestis M.A. \u03949-Tetrahydrocannabinol (THC), 11-Hydroxy-THC, and 11-Nor-9-Carboxy-THC Plasma Pharmacokinetics during and after Continuous High-Dose Oral THC. Clin. Chem. 2009;55:2180\u20132189. doi: 10.1373/clinchem.2008.122119.", "ArticleIdList": ["10.1373/clinchem.2008.122119", "PMC3196989", "19833841"]}, {"Citation": "Martin B.R., Jefferson R., Winckler R., Wiley J.L., Huffman J.W., Crocker P.J., Saha B., Razdan R.K. Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists. J. Pharmacol. Exp. Ther. 1999;290:1065\u20131079.", "ArticleIdList": ["10454479"]}, {"Citation": "Andersson D.A., Gentry C., Alenmyr L., Killander D., Lewis S.E., Andersson A., Bucher B., Galzi J.-L., Sterner O., Bevan S. TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid. \u03b4 9-tetrahydrocannabiorcol. Nat. Commun. 2011;2:551. doi: 10.1038/ncomms1559.", "ArticleIdList": ["10.1038/ncomms1559", "22109525"]}, {"Citation": "Bow E.W., Rimoldi J.M. The structure\u2013function relationships of classical cannabinoids: CB1/CB2 modulation. Perspect. Med. Chem. 2016;8:17\u201339. doi: 10.4137/PMC.S32171.", "ArticleIdList": ["10.4137/PMC.S32171", "PMC4927043", "27398024"]}, {"Citation": "Thomas A., Ross R.A., Saha B., Mahadevan A., Razdan R.K., Pertwee R.G. 6\u2033-azidohex-2\u2033-yne-cannabidiol: A potential neutral, competitive cannabinoid cb1 receptor antagonist. Eur. J. Pharmacol. 2004;487:213\u2013221. doi: 10.1016/j.ejphar.2004.01.023.", "ArticleIdList": ["10.1016/j.ejphar.2004.01.023", "15033394"]}, {"Citation": "O\u2019Donnell B., Meissner H., Gupta V.  StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2023.  [(accessed on 27 June 2023)]. Dronabinol. Updated 5 September 2022. Available online:  https://www.ncbi.nlm.nih.gov/books/NBK557531/"}, {"Citation": "(R)-(+)-Methanandamide.  [(accessed on 3 May 2023)].  Available online:  https://www.tocris.com/products/r-methanandamide_1121."}, {"Citation": "Gratzke C., Streng T., Stief C.G., Downs T.R., Alroy I., Rosenbaum J.S., Andersson K.E., Hedlund P. Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats. Eur. Urol. 2010;57:1093\u20131100. doi: 10.1016/j.eururo.2010.02.027.", "ArticleIdList": ["10.1016/j.eururo.2010.02.027", "20207474"]}, {"Citation": "D\u2019Aquila P.S. Microstructure analysis of the effects of the cannabinoid agents HU-210 and rimonabant in rats licking for sucrose. Eur. J. Pharmacol. 2020;887:173468. doi: 10.1016/j.ejphar.2020.173468.", "ArticleIdList": ["10.1016/j.ejphar.2020.173468", "32781169"]}, {"Citation": "Ikeda H., Ikegami M., Kai M., Ohsawa M., Kamei J. Activation of spinal cannabinoid CB2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice. Neuroscience. 2013;250:446\u2013454. doi: 10.1016/j.neuroscience.2013.07.040.", "ArticleIdList": ["10.1016/j.neuroscience.2013.07.040", "23892011"]}, {"Citation": "Du J.J., Liu Z.Q., Yan Y., Xiong J., Jia X.T., Di Z.L., Ren J.J. The Cannabinoid WIN 55,212-2 Reduces Delayed Neurologic Sequelae After Carbon Monoxide Poisoning by Promoting Microglial M2 Polarization Through ST2 Signaling. J. Mol. Neurosci. MN. 2020;70:422\u2013432. doi: 10.1007/s12031-019-01429-2.", "ArticleIdList": ["10.1007/s12031-019-01429-2", "31732924"]}, {"Citation": "Verty A.N., Stefanidis A., McAinch A.J., Hryciw D.H., Oldfield B. Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice. PLoS ONE. 2015;10:e0140592. doi: 10.1371/journal.pone.0140592.", "ArticleIdList": ["10.1371/journal.pone.0140592", "PMC4654496", "26588700"]}, {"Citation": "Howlett A.C., Thomas B.F., Huffman J.W. The Spicy Story of Cannabimimetic Indoles. Molecules. 2021;26:6190. doi: 10.3390/molecules26206190.", "ArticleIdList": ["10.3390/molecules26206190", "PMC8538531", "34684770"]}, {"Citation": "Abadji V., Lin S., Taha G., Griffin G., Stevenson L.A., Pertwee R.G., Makriyannis A. (R)-Methanandamide: A Chiral Novel Anandamide Possessing Higher Potency and Metabolic Stability. J. Med. Chem. 1994;37:1889\u20131893. doi: 10.1021/jm00038a020.", "ArticleIdList": ["10.1021/jm00038a020", "8021930"]}, {"Citation": "WIN 55212-2.  [(accessed on 3 May 2023)]; Available online:  https://pubchem.ncbi.nlm.nih.gov/compound/5311501."}, {"Citation": "JWH-133.  [(accessed on 3 May 2023)]; Available online:  https://pubchem.ncbi.nlm.nih.gov/compound/6918505."}, {"Citation": "Hassenberg C., Clausen F., Hoffmann G., Studer A., Sch\u00fcrenkamp J. Investigation of phase II metabolism of 11-hydroxy-\u0394-9-tetrahydrocannabinol and metabolite verification by chemical synthesis of 11-hydroxy-\u0394-9-tetrahydrocannabinol-glucuronide. Int. J. Legal Med. 2020;134:2105\u20132119. doi: 10.1007/s00414-020-02387-w.", "ArticleIdList": ["10.1007/s00414-020-02387-w", "PMC7578173", "32808050"]}, {"Citation": "Engels F.K., de Jong F.A., Mathijssen R.H.J., Erkens J.A., Herings R.M., Verweij J. Medicinal Cannabis in Oncology. Eu. J. Cancer. 2007;43:2638\u20132644. doi: 10.1016/j.ejca.2007.09.010.", "ArticleIdList": ["10.1016/j.ejca.2007.09.010", "17976975"]}, {"Citation": "Ward S.J., McAllister S.D., Kawamura R., Murase R., Neelakantan H., Walker E.A. Cannabidiol Inhibits Paclitaxel-Induced Neuropathic Pain through 5-HT1A Receptors without Diminishing Nervous System Function or Chemotherapy Efficacy. Br. J. Pharmacol. 2014;171:636\u2013645. doi: 10.1111/bph.12439.", "ArticleIdList": ["10.1111/bph.12439", "PMC3969077", "24117398"]}, {"Citation": "Keating G.M. Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex\u00ae): A Review in Multiple Sclerosis-Related Spasticity. Drugs. 2017;77:563\u2013574. doi: 10.1007/s40265-017-0720-6.", "ArticleIdList": ["10.1007/s40265-017-0720-6", "28293911"]}, {"Citation": "Reddy D.S., Golub M.V. The Pharmacological Basis of Cannabis Therapy for Epilepsy. J. Pharmacol. Exp. Ther. 2016;357:45. doi: 10.1124/jpet.115.230151.", "ArticleIdList": ["10.1124/jpet.115.230151", "26787773"]}, {"Citation": "Navarro G., Gonzalez A., S\u00e1nchez-Morales A., Casajuana-Martin N., G\u00f3mez-Ventura M., Cordom\u00ed A., Busqu\u00e9 F., Alib\u00e9s R., Pardo L., Franco R. Design of Negative and Positive Allosteric Modulators of the Cannabinoid CB2 Receptor Derived from the Natural Product Cannabidiol. J. Med. Chem. 2021;64:9354\u20139364. doi: 10.1021/acs.jmedchem.1c00561.", "ArticleIdList": ["10.1021/acs.jmedchem.1c00561", "34161090"]}, {"Citation": "Luft F.C. Rehabilitating rimonabant. J. Mol. Med. 2013;91:777\u2013779. doi: 10.1007/s00109-013-1039-8.", "ArticleIdList": ["10.1007/s00109-013-1039-8", "23591956"]}, {"Citation": "Karas J.A., Wong L.J.M., Paulin O.K.A., Mazeh A.C., Hussein M.H., Li J., Velkov T. The Antimicrobial Activity of Cannabinoids. Antibiotics. 2020;9:406. doi: 10.3390/antibiotics9070406.", "ArticleIdList": ["10.3390/antibiotics9070406", "PMC7400265", "32668669"]}, {"Citation": "Stone N.L., Murphy A.J., England T.J., O\u2019Sullivan S.E. A Systematic Review of Minor Phytocannabinoids with Promising Neuroprotective Potential. Br. J. Pharmacol. 2020;177:4330\u20134352. doi: 10.1111/bph.15185.", "ArticleIdList": ["10.1111/bph.15185", "PMC7484504", "32608035"]}, {"Citation": "Walsh K.B., McKinney A.E., Holmes A.E. Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses. Front. Pharmacol. 2021;12:777804. doi: 10.3389/fphar.2021.777804.", "ArticleIdList": ["10.3389/fphar.2021.777804", "PMC8669157", "34916950"]}, {"Citation": "Scott C., Neira Agonh D., Lehmann C. Antibacterial Effects of Phytocannabinoids. Life. 2022;12:1394. doi: 10.3390/life12091394.", "ArticleIdList": ["10.3390/life12091394", "PMC9505641", "36143430"]}, {"Citation": "van Klingeren B., ten Ham M. Antibacterial Activity of \u03949-Tetrahydrocannabinol and Cannabidiol. Antonie Leeuwenhoek. 1976;42:9\u201312. doi: 10.1007/BF00399444.", "ArticleIdList": ["10.1007/BF00399444", "1085130"]}, {"Citation": "Appendino G., Gibbons S., Giana A., Pagani A., Grassi G., Stavri M., Smith E., Rahman M.M. Antibacterial cannabinoids from Cannabis sativa: A structure-activity study. J. Nat. Prod. 2008;71:1427\u20131430. doi: 10.1021/np8002673.", "ArticleIdList": ["10.1021/np8002673", "18681481"]}, {"Citation": "Martinenghi L.D., J\u00f8nsson R., Lund T., Jenssen H. Isolation, purification, and antimicrobial characterization of cannabidiolic acid and cannabidiol from Cannabis sativa L. Biomolecules. 2020;10:900. doi: 10.3390/biom10060900.", "ArticleIdList": ["10.3390/biom10060900", "PMC7355595", "32545687"]}, {"Citation": "Wu Q., Guo M., Zou L., Wang Q., Xia Y. 8,9-Dihydrocannabidiol, an Alternative of Cannabidiol, Its Preparation, Antibacterial and Antioxidant Ability. Molecules. 2023;28:445. doi: 10.3390/molecules28010445.", "ArticleIdList": ["10.3390/molecules28010445", "PMC9824641", "36615636"]}, {"Citation": "Wassmann C.S., H\u00f8jrup P., Klitgaard J.K. Cannabidiol Is an Effective Helper Compound in Combination with Bacitracin to Kill Gram-Positive Bacteria. Sci. Rep. 2020;10:4112. doi: 10.1038/s41598-020-60952-0.", "ArticleIdList": ["10.1038/s41598-020-60952-0", "PMC7057955", "32139776"]}, {"Citation": "Turner C.E., Elsohly M.A. Biological activity of cannabichromene, its homologs and isomers. J. Clin. Pharmacol. 1981;21:283s\u2013291s. doi: 10.1002/j.1552-4604.1981.tb02606.x.", "ArticleIdList": ["10.1002/j.1552-4604.1981.tb02606.x", "7298870"]}, {"Citation": "Aqawi M., Sionov R.V., Gallily R., Friedman M., Steinberg D. Anti-Bacterial Properties of Cannabigerol Toward Streptococcus Mutans. Front. Microbiol. 2021;12:656471. doi: 10.3389/fmicb.2021.656471.", "ArticleIdList": ["10.3389/fmicb.2021.656471", "PMC8100047", "33967995"]}, {"Citation": "Elsohly H.N., Turner C.E., Clark A.M., Elsohly M.A. Synthesis and Antimicrobial Activities of Certain Cannabichromene and Cannabigerol Related Compounds. J. Pharm. Sci. 1982;71:1319\u20131323. doi: 10.1002/jps.2600711204.", "ArticleIdList": ["10.1002/jps.2600711204", "7153877"]}, {"Citation": "Feldman M., Smoum R., Mechoulam R., Steinberg D. Antimicrobial potential of endocannabinoid and endocannabinoid-like compounds against methicillin-resistant Staphylococcus aureus. Sci. Rep. 2018;8:17696. doi: 10.1038/s41598-018-35793-7.", "ArticleIdList": ["10.1038/s41598-018-35793-7", "PMC6283871", "30523307"]}, {"Citation": "CLSI.  [(accessed on 3 May 2023)].  Available online:  https://clsi.org/"}, {"Citation": "Kosgodage U.S., Matewele P., Awamaria B., Kraev I., Warde P., Mastroianni G., Nunn A.V., Guy G.W., Bell J.D., Inal J.M., et al. Cannabidiol Is a novel modulator of bacterial membrane vesicles. Front. Cell. Infect. Microbiol. 2019;9:324. doi: 10.3389/fcimb.2019.00324.", "ArticleIdList": ["10.3389/fcimb.2019.00324", "PMC6747004", "31552202"]}, {"Citation": "Seccamani P., Franco C., Protti S., Porta A., Profumo A., Caprioglio D., Salamone S., Mannucci B., Merli D. Photochemistry of Cannabidiol (CBD) Revised. A Combined Preparative and Spectrometric Investigation. J. Nat. Prod. 2021;84:2858\u20132865. doi: 10.1021/acs.jnatprod.1c00567.", "ArticleIdList": ["10.1021/acs.jnatprod.1c00567", "PMC8765678", "34668704"]}, {"Citation": "Luo G.-Y., Wu H., Tang Y., Li H., Yeom H.-S., Yang K., Hsung R.P. A Total Synthesis of (\u00b1)-Rhododaurichromanic Acid A via an Oxa-[3+3] Annulation of Resorcinols. Synthesis. 2015;47:2713\u20132720. doi: 10.1055/s-0034-1380429.", "ArticleIdList": ["10.1055/s-0034-1380429"]}, {"Citation": "Lodewyk M.W., Lui V.G., Tantillo D.J. Synthesis of (Sulfonyl)Methylphosphonate Analogs of Prenyl Diphosphates. Tetrahedron Lett. 2010;51:170\u2013173. doi: 10.1016/j.tetlet.2009.10.119.", "ArticleIdList": ["10.1016/j.tetlet.2009.10.119"]}, {"Citation": "Yeom H.-S., Li H., Tang Y., Hsung R.P. Total Syntheses of Cannabicyclol, Clusiacyclol A and B, Iso-Eriobrucinol A and B, and Eriobrucinol. Org. Lett. 2013;15:3130\u20133133. doi: 10.1021/ol401335u.", "ArticleIdList": ["10.1021/ol401335u", "23730958"]}, {"Citation": "Crombie L., Ponsford R., Shani A., Yagnitinsky B., Mechoulam R. Hashish Components. Photochemical Production of Cannabicyclol from Cannabichromene. Tetrahedron Lett. 1968;9:5771\u20135772. doi: 10.1016/S0040-4039(00)76346-5.", "ArticleIdList": ["10.1016/S0040-4039(00)76346-5", "5697175"]}, {"Citation": "Schafroth M.A., Mazzoccanti G., Reynoso-Moreno I., Erni R., Pollastro F., Caprioglio D., Botta B., Allegrone G., Grassi G., Chicca A., et al. \u03949-Cis-Tetrahydrocannabinol: Natural Occurrence, Chirality, and Pharmacology. J. Nat. Prod. 2021;84:2502\u20132510. doi: 10.1021/acs.jnatprod.1c00513.", "ArticleIdList": ["10.1021/acs.jnatprod.1c00513", "34304557"]}, {"Citation": "Andersen L.L., Ametovski A., Lin Luo J., Everett-Morgan D., McGregor I.S., Banister S.D., Arnold J.C. Cannabichromene, Related Phytocannabinoids, and 5-Fluoro-Cannabichromene Have Anticonvulsant Properties in a Mouse Model of Dravet Syndrome. ACS Chem. Neurosci. 2021;12:330\u2013339. doi: 10.1021/acschemneuro.0c00677.", "ArticleIdList": ["10.1021/acschemneuro.0c00677", "33395525"]}, {"Citation": "Lee Y.R., Wang X. Concise Synthesis of Biologically Interesting (\u2032)-Cannabichromene, (\u2032)-Cannabichromenic Acid, and (\u2032)-Daurichromenic Acid. Bull. Korean Chem. Soc. 2005;26:1933\u20131936. doi: 10.1002/chin.200616210.", "ArticleIdList": ["10.1002/chin.200616210"]}, {"Citation": "Tietze L.-F., Kiedrowski G.V., Berger B. A New Method of Aromatization of Cyclohexenone Derivatives; Synthesis of Cannabichromene. Synthesis. 1982;8:683\u2013684. doi: 10.1055/s-1982-29902.", "ArticleIdList": ["10.1055/s-1982-29902"]}, {"Citation": "Eisohly M.A., Boeren E.G., Turner C.E. Constituents of Cannabis Sativa L. An Improved Method for the Synthesis of Dl-Cannabichromene. J. Heterocycl. Chem. 1978;15:699\u2013700. doi: 10.1002/jhet.5570150441.", "ArticleIdList": ["10.1002/jhet.5570150441"]}, {"Citation": "Qu\u00edlez del Moral J.F., Ruiz Mart\u00ednez C., P\u00e9rez del Pulgar H., Mart\u00edn Gonz\u00e1lez J.E., Fern\u00e1ndez I., L\u00f3pez-P\u00e9rez J.L., Fern\u00e1ndez-Arteaga A., Barrero A.F. Synthesis of Cannabinoids: \u201cIn Water\u201d and \u201cOn Water\u201d Approaches: Influence of SDS Micelles. J. Org. Chem. 2021;86:3344\u20133355. doi: 10.1021/acs.joc.0c02698.", "ArticleIdList": ["10.1021/acs.joc.0c02698", "PMC9087200", "33533618"]}, {"Citation": "Yamaguchi S., Shouji N., Kuroda K. A New Approach to Dl-Cannabichromene. BCSJ. 1995;68:305\u2013308. doi: 10.1246/bcsj.68.305.", "ArticleIdList": ["10.1246/bcsj.68.305"]}, {"Citation": "Gaoni Y., Mechoulam R. The Structure and Synthesis of Cannabigerol, a New Hashish Constituent. Proc. Chem. Soc. 1964;82"}, {"Citation": "Mechoulam R., Yagen B. Stereoselective Cyclizations of Cannabinoid 1,5 Dienes. Tetrahedron Lett. 1969;10:5349\u20135352. doi: 10.1016/S0040-4039(01)88961-9.", "ArticleIdList": ["10.1016/S0040-4039(01)88961-9", "5370765"]}, {"Citation": "Taura F., Morimoto S., Shoyama Y. Purification and Characterization of Cannabidiolic-Acid Synthase from Cannabis Sativa L.: Biochemical analysis of a novel enzyme that catalyzes the oxidocyclization of cannabigerolic acid to cannabidiolic acid. J. Biol. Chem. 1996;271:17411\u201317416. doi: 10.1074/jbc.271.29.17411.", "ArticleIdList": ["10.1074/jbc.271.29.17411", "8663284"]}, {"Citation": "Baek S.H., Srebnik M., Mechoulam R. Boron Trifluoride Etherate on Alumina\u2014A Modified Lewis Acid Reagent. An Improved Synthesis of Cannabidiol. Tetrahedron Lett. 1985;26:1083\u20131086. doi: 10.1016/S0040-4039(00)98518-6.", "ArticleIdList": ["10.1016/S0040-4039(00)98518-6"]}, {"Citation": "Baek S.-H., Yook C.N., Han D.S. Boron trifluoride etherate on alumina\u2014A modified Lewis acid reagent(V) a convenient single-step synthesis of cannabinoids. Bull. Korean Chem. Soc. 1995;16:293\u2013296."}, {"Citation": "Baek S.-H., Du Han S., Yook C.N., Kim Y.C., Kwak J.S. Synthesis and Antitumor Activity of Cannabigerol. Arch. Pharm. Res. 1996;19:228\u2013230. doi: 10.1007/BF02976895.", "ArticleIdList": ["10.1007/BF02976895"]}, {"Citation": "Kumano T., Richard S.B., Noel J.P., Nishiyama M., Kuzuyama T. Chemoenzymatic Syntheses of Prenylated Aromatic Small Molecules Using Streptomyces Prenyltransferases with Relaxed Substrate Specificities. Bioorg. Med. Chem. 2008;16:8117\u20138126. doi: 10.1016/j.bmc.2008.07.052.", "ArticleIdList": ["10.1016/j.bmc.2008.07.052", "PMC2860626", "18682327"]}, {"Citation": "Jentsch N.G., Zhang X., Magolan J. Efficient Synthesis of Cannabigerol, Grifolin, and Piperogalin via Alumina-Promoted Allylation. J. Nat. Prod. 2020;83:2587\u20132591. doi: 10.1021/acs.jnatprod.0c00131.", "ArticleIdList": ["10.1021/acs.jnatprod.0c00131", "32972142"]}, {"Citation": "Curtis B.J., Micikas R.J., Burkhardt R.N., Smith R.A., Pan J.Y., Jander K., Schroeder F.C. Syntheses of Amorfrutins and Derivatives via Tandem Diels\u2013Alder and Anionic Cascade Approaches. J. Org. Chem. 2021;86:11269\u201311276. doi: 10.1021/acs.joc.0c03043.", "ArticleIdList": ["10.1021/acs.joc.0c03043", "PMC8594413", "33661630"]}, {"Citation": "Mechoulam R., Gaoni Y. A Total Synthesis of Dl-\u03941-Tetrahydrocannabinol, the Active Constituent of Hashish1. J. Am. Chem. Soc. 1965;87:3273\u20133275. doi: 10.1021/ja01092a065.", "ArticleIdList": ["10.1021/ja01092a065", "14324315"]}, {"Citation": "Petrzilka T., Haefliger W., Sikemeier C., Ohloff G., Eschenmoser A. Synthese Und Chiralit\u00e4t Des (\u2212)-Cannabidiols Vorl\u00e4ufige Mitteilung. Helvetica Chim. Acta. 1967;50:719\u2013723. doi: 10.1002/hlca.19670500235.", "ArticleIdList": ["10.1002/hlca.19670500235", "5587099"]}, {"Citation": "Petrzilka T., Haefliger W., Sikemeier C. Synthese von Haschisch-Inhaltsstoffen. 4. Mitteilung. Helvetica Chim. Acta. 1969;52:1102\u20131134. doi: 10.1002/hlca.19690520427.", "ArticleIdList": ["10.1002/hlca.19690520427"]}, {"Citation": "Razdan R.K., Dalzell H.C., Handrick G.R. Hashish. X. Simple One-Step Synthesis of (\u2212)-DELTA.1-Tetrahydrocannabinol (THC) from p-Mentha-2,8-Dien-1-Ol and Olivetol. J. Am. Chem. Soc. 1974;96:5860\u20135865. doi: 10.1021/ja00825a026.", "ArticleIdList": ["10.1021/ja00825a026", "4413630"]}, {"Citation": "Papahatjis D.P., Nikas S.P., Andreou T., Makriyannis A. Novel 1\u2032,1\u2032-Chain Substituted \u03948-Tetrahydrocannabinols. Bioorg. Med. Chem. Lett. 2002;12:3583\u20133586. doi: 10.1016/S0960-894X(02)00785-0.", "ArticleIdList": ["10.1016/S0960-894X(02)00785-0", "12443781"]}, {"Citation": "Uliss D.B., Dalzell H.C., Handrick G.R., Howes J.F., Razdan R.K. Hashish. Importance of the Phenolic Hydroxyl Group in Tetrahydrocannabinols. J. Med. Chem. 1975;18:213\u2013215. doi: 10.1021/jm00236a025.", "ArticleIdList": ["10.1021/jm00236a025", "1120991"]}, {"Citation": "Crombie L., Crombie W.M.L., Jamieson S.V., Palmer C.J. Acid-Catalysed Terpenylations of Olivetol in the Synthesis of Cannabinoids. J. Chem. Soc. Perkin Trans. 1988;1:1243\u20131250. doi: 10.1039/p19880001243.", "ArticleIdList": ["10.1039/p19880001243"]}, {"Citation": "Kinney W.A., McDonnell M.E., Zhong H.M., Liu C., Yang L., Ling W., Qian T., Chen Y., Cai Z., Petkanas D., et al. Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, with Improved Potency, Safety, and Permeability. ACS Med. Chem. Lett. 2016;7:424\u2013428. doi: 10.1021/acsmedchemlett.6b00009.", "ArticleIdList": ["10.1021/acsmedchemlett.6b00009", "PMC4834656", "27096053"]}, {"Citation": "Villano R., Straker H., Di Marzo V. Short and Efficient Synthesis of Alkylresorcinols: A Route for the Preparation of Cannabinoids. New J. Chem. 2022;46:20664\u201320668. doi: 10.1039/D2NJ03547B.", "ArticleIdList": ["10.1039/D2NJ03547B"]}, {"Citation": "Vaillancourt V., Albizati K.F. A One-Step Method for the.Alpha.-Arylation of Camphor. Synthesis of (\u2212)-Cannabidiol and (\u2212)-Cannabidiol Dimethyl Ether. J. Org. Chem. 1992;57:3627\u20133631. doi: 10.1021/jo00039a022.", "ArticleIdList": ["10.1021/jo00039a022"]}, {"Citation": "Malkov A., Kocovsky P. Tetrahydrocannabinol Revisited: Synthetic Approaches Utilizing Molybdenum Catalysts. Collect. Czech. Chem. Commun. 2001;66:1257\u20131268. doi: 10.1135/cccc20011257.", "ArticleIdList": ["10.1135/cccc20011257"]}, {"Citation": "William A.D., Kobayashi Y. A Method To Accomplish a 1,4-Addition Reaction of Bulky Nucleophiles to Enones and Subsequent Formation of Reactive Enolates. Org. Lett. 2001;3:2017\u20132020. doi: 10.1021/ol010071i.", "ArticleIdList": ["10.1021/ol010071i", "11418038"]}, {"Citation": "Kobayashi Y., Takeuchi A., Wang Y.-G. Synthesis of Cannabidiols via Alkenylation of Cyclohexenyl Monoacetate. Org. Lett. 2006;8:2699\u20132702. doi: 10.1021/ol060692h.", "ArticleIdList": ["10.1021/ol060692h", "16774235"]}, {"Citation": "Shultz Z.P., Lawrence G.A., Jacobson J.M., Cruz E.J., Leahy J.W. Enantioselective Total Synthesis of Cannabinoids\u2014A Route for Analogue Development. Org. Lett. 2018;20:381\u2013384. doi: 10.1021/acs.orglett.7b03668.", "ArticleIdList": ["10.1021/acs.orglett.7b03668", "29293352"]}, {"Citation": "Gong X., Sun C., Abame M.A., Shi W., Xie Y., Xu W., Zhu F., Zhang Y., Shen J., Aisa H.A. Synthesis of CBD and Its Derivatives Bearing Various C4\u2032-Side Chains with a Late-Stage Diversification Method. J. Org. Chem. 2020;85:2704\u20132715. doi: 10.1021/acs.joc.9b02880.", "ArticleIdList": ["10.1021/acs.joc.9b02880", "31885270"]}, {"Citation": "Chiurchi\u00f9 E., Sampaolesi S., Allegrini P., Ciceri D., Ballini R., Palmieri A. A Novel and Practical Continuous Flow Chemical Synthesis of Cannabidiol (CBD) and Its CBDV and CBDB Analogues. Eur. J. Org. Chem. 2021;2021:1286\u20131289. doi: 10.1002/ejoc.202001633.", "ArticleIdList": ["10.1002/ejoc.202001633"]}, {"Citation": "Anand R., Cham P.S., Gannedi V., Sharma S., Kumar M., Singh R., Vishwakarma R.A., Singh P.P. Stereoselective Synthesis of Nonpsychotic Natural Cannabidiol and Its Unnatural/Terpenyl/Tail-Modified Analogues. J. Org. Chem. 2022;87:4489\u20134498. doi: 10.1021/acs.joc.1c02571.", "ArticleIdList": ["10.1021/acs.joc.1c02571", "35289168"]}, {"Citation": "Grimm J.A.A., Zhou H., Properzi R., Leutzsch M., Bistoni G., Nienhaus J., List B. Catalytic Asymmetric Synthesis of Cannabinoids and Menthol from Neral. Nature. 2023;615:634\u2013639. doi: 10.1038/s41586-023-05747-9.", "ArticleIdList": ["10.1038/s41586-023-05747-9", "PMC10033408", "36859552"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "5", "Day": "14"}, {"Year": "2023", "Month": "6", "Day": "27"}, {"Year": "2023", "Month": "7", "Day": "1"}, {"Year": "2023", "Month": "7", "Day": "29", "Hour": "11", "Minute": "46"}, {"Year": "2023", "Month": "7", "Day": "29", "Hour": "11", "Minute": "45"}, {"Year": "2023", "Month": "7", "Day": "29", "Hour": "1", "Minute": "39"}, {"Year": "2023", "Month": "7", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["37514074", "PMC10384972", "10.3390/pharmaceutics15071889", "pharmaceutics15071889"]}}], "PubmedBookArticle": []}